课题基金 / 基金详情

An Innovative Approach for Profiling Protein Kinase Substrates

An Innovative Approach for Profiling Protein Kinase Substrates
分析蛋白激酶底物的创新方法
批准号:
7916888
负责人:
CHARLES J. BIEBERICH
金额:
$2.61万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-05-10 至 2010-04-30

项目摘要

项目成果

CHARLES J. BIEBERICH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Signal transduction is a central component of nearly all biological processes. Protein kinases play critical roles in signaling pathways by phosphorylating proteins involved in signal amplification and in executing the cellular response to extrinsic or intrinsic stimuli. Aberrant kinase signaling plays a role in the etiology of nearly all cancers and in hundreds of other diseases. Systematic approaches to the elucidation of the signaling pathways driven by kinases have the potential to illuminate new points of therapeutic intervention. The identification of physiologic kinase substrates is an important component of this endeavor. Currently, there is a need for technologies that can be widely deployed to approach this problem. We are developing a simple, straightforward technique for kinase substrate profiling that we term the reverse in-gel kinase assay. This assay enables the discovery of kinase substrates in whole or pre-fractionated complex biological extracts. If properly developed and validated, this assay has the potential, through the concerted effort of multiple laboratories, to enable rapid identification of potential physiologic substrates of many kinases.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/pr3000514
发表时间: 2012-07-06
期刊: Journal of proteome research
影响因子: 4.4
作者: [Li X, Rao V, Jin J, Guan B, Anderes KL, Bieberich CJ]
通讯作者: Bieberich CJ
Heteroduplex thermostable ligation assembly: a new platform to rapidly generate large DNA molecules
  • 批准号:
    10383266
  • 项目类别:
  • 资助金额:
    $25.66万
  • 财政年份:
    2021
  • 负责人:
    CHARLES J. BIEBERICH
  • 依托单位:
Developing a strategy to identify & validate pharmacodynamic kinase inhibitor biomarkers
Role of TRPA1 & TRPV1 in pain and voiding symptoms in a new mouse CP/CPPS model
Application of an Innovative Technology to Develop Low Toxicity Kinase Inhibitors
海外基金